<HashMap><database>biostudies-literature</database><scores/><additional><submitter>De Gasperi R</submitter><funding>BLRD VA</funding><funding>NIA NIH HHS</funding><funding>RRD VA</funding><pagination>714-733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10902502</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(5-6)</volume><pubmed_abstract>Many military veterans who experienced blast-related traumatic brain injuries in the conflicts in Iraq and Afghanistan currently suffer from chronic cognitive and mental health problems that include depression and post-traumatic stress disorder (PTSD). Male rats exposed to repetitive low-level blast develop cognitive and PTSD-related behavioral traits that are present for more than 1 year after exposure. We previously reported that a group II metabotropic receptor (mGluR2/3) antagonist reversed blast-induced behavioral traits. In this report, we explored mGluR2/3 expression following blast exposure in male rats. Western blotting revealed that mGluR2 protein (but not mGluR3) was increased in all brain regions studied (anterior cortex, hippocampus, and amygdala) at 43 or 52 weeks after blast</pubmed_abstract><journal>Journal of neurotrauma</journal><pubmed_title>Metabotropic Glutamate Receptor 2 Expression Is Chronically Elevated in Male Rats With Post-Traumatic Stress Disorder Related Behavioral Traits Following Repetitive Low-Level Blast Exposure.</pubmed_title><pmcid>PMC10902502</pmcid><funding_grant_id>I01 RX002660</funding_grant_id><funding_grant_id>I01 BX005882</funding_grant_id><funding_grant_id>P30 AG066514</funding_grant_id><funding_grant_id>I21 RX003459</funding_grant_id><funding_grant_id>I01 RX003846</funding_grant_id><pubmed_authors>Patterson J</pubmed_authors><pubmed_authors>Cook DG</pubmed_authors><pubmed_authors>Abutarboush R</pubmed_authors><pubmed_authors>Hof PR</pubmed_authors><pubmed_authors>Morrison CL</pubmed_authors><pubmed_authors>Pryor D</pubmed_authors><pubmed_authors>Elder GA</pubmed_authors><pubmed_authors>De Gasperi R</pubmed_authors><pubmed_authors>Gama Sosa MA</pubmed_authors><pubmed_authors>Lind R</pubmed_authors><pubmed_authors>Statz JK</pubmed_authors><pubmed_authors>Zhu CW</pubmed_authors><pubmed_authors>Ahlers ST</pubmed_authors><pubmed_authors>Kawoos U</pubmed_authors><pubmed_authors>Perez GM</pubmed_authors><pubmed_authors>Perez Garcia G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabotropic Glutamate Receptor 2 Expression Is Chronically Elevated in Male Rats With Post-Traumatic Stress Disorder Related Behavioral Traits Following Repetitive Low-Level Blast Exposure.</name><description>Many military veterans who experienced blast-related traumatic brain injuries in the conflicts in Iraq and Afghanistan currently suffer from chronic cognitive and mental health problems that include depression and post-traumatic stress disorder (PTSD). Male rats exposed to repetitive low-level blast develop cognitive and PTSD-related behavioral traits that are present for more than 1 year after exposure. We previously reported that a group II metabotropic receptor (mGluR2/3) antagonist reversed blast-induced behavioral traits. In this report, we explored mGluR2/3 expression following blast exposure in male rats. Western blotting revealed that mGluR2 protein (but not mGluR3) was increased in all brain regions studied (anterior cortex, hippocampus, and amygdala) at 43 or 52 weeks after blast</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T00:48:59.816Z</modification><creation>2025-04-04T00:48:59.816Z</creation></dates><accession>S-EPMC10902502</accession><cross_references><pubmed>37917117</pubmed><doi>10.1089/neu.2023.0252</doi></cross_references></HashMap>